Relief Therapeutics Holding AG (RLFTF)

[PennyWorld]

RLFTF management has requested the 'data' from the NIH study. My guess is that that will take a couple of months or so. Until the data is assessed by an expert, we just don't know all of the specifics of the trial (IMO). There's been a lot of speculation that the trial was improperly designed which was a formula for failure.

We do know that Dr JJ study was targeted for late stage patients, so possibly NIH tried to mirror that for validation purposes.

India clearly has seen benefit from their study, hence their issuance of EUA. So there is clearly some sort of mismatch between the trials. The devil is in the details. You have probably already seen this report on outcome of the India study. https://acrobat.adobe.com/link/review?uri=urn%3Aaaid%3Ascds%3AUS%3A91aa11ad-10cc-3179-8838-1a6d8b949439&fbclid=IwAR005OpIYAc0QcsmmB78gNm4EDk46WeImEX4sgtJ3xE5RUr4sSShD7ZiiJA&fs=e&s=cl#pageNum=1